| Issue Date | Title | Author(s) |
| 2017-11-08 | Linking EPCR-Binding PfEMP1 to Brain Swelling in Pediatric Cerebral Malaria | Kessler, A; Dankwa, S; Bernabeu, M; Harawa, V; Danziger, SA; Duffy, F; Kampondeni, SD; Potchen, MJ; Dambrauskas, N; Vigdorovich, V; Oliver, BG; Hochman, SE; Mowrey, WB; MacCormick, IJC; Mandala, WL; Rogerson, SJ; Sather, DN; Aitchison, JD; Taylor, TE; Seydel, KB; Smith, JD; Kim, K |
| 2013-12-01 | MicroRNA control of interferons and interferon induced anti-viral activity | Sedger, LM |
| 2001-01-15 | Secreted lymphotoxin-α is essential for the control of an intracellular bacterial infection | Roach, DR; Briscoe, H; Saunders, B; France, MP; Riminton, S; Britton, WJ |
| 2007-02-01 | TNF-dependent overexpression of CCL21 is an underlying cause of progressive lympoaccumulation in generalized lymphoproliferative disorder | Wiede, F; Vana, K; Sedger, LM; Lechner, A; Körner, H |
| 2013-01-01 | On the efficacy and safety of vaccination with live tachyzoites of Neospora caninum for prevention of Neospora-associated fetal loss in cattle | Weber, FH; Jackson, JA; Sobecki, B; Choromanski, L; Olsen, M; Meinert, T; Frank, R; Reichel, MP; Ellis, JT |
| 2012-09-06 | CD86<sup>+</sup>or HLA-G<sup>+</sup> can be transferred via trogocytosis from myeloma cells to T cells and are associated with poor prognosis | Brown, R; Kabani, K; Favaloro, J; Yang, S; Ho, PJ; Gibson, J; Fromm, P; Suen, H; Woodland, N; Nassif, N; Hart, D; Joshua, D |
| 2017-07-01 | Modeling T<inf>H</inf>2 responses and airway inflammation to understand fundamental mechanisms regulating the pathogenesis of asthma | Foster, PS; Maltby, S; Rosenberg, HF; Tay, HL; Hogan, SP; Collison, AM; Yang, M; Kaiko, GE; Hansbro, PM; Kumar, RK; Mattes, J |
| 2014-01-01 | Myeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myeloma | Favaloro, J; Liyadipitiya, T; Brown, R; Yang, S; Suen, H; Woodland, N; Nassif, N; Hart, D; Fromm, P; Weatherburn, C; Gibson, J; Ho, PJ; Joshua, D |
| 2019-10-01 | RIPLET, and not TRIM25, is required for endogenous RIG-I-dependent antiviral responses | Hayman, TJ; Hsu, AC; Kolesnik, TB; Dagley, LF; Willemsen, J; Tate, MD; Baker, PJ; Kershaw, NJ; Kedzierski, L; Webb, AI; Wark, PA; Kedzierska, K; Masters, SL; Belz, GT; Binder, M; Hansbro, PM; Nicola, NA; Nicholson, SE |
| 2010-09-01 | Concise review: Nanoparticles and cellular carriers-allies in cancer imaging and cellular gene therapy? | Tang, C; Russell, PJ; Martiniello-Wilks, R; Rasko, JEJ; Khatri, A |
